AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2021
Jun 29, 2021
34129_dirs_2021-06-28_89c1306b-713e-4846-af25-aca7662b851a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2021-06-24
Reporting Person: Bonvini Ezio (Sr VP, Research & CSO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-24 | Common Stock | M | 21855 | $16 | Acquired | 104329 | Direct |
| 2021-06-24 | Common Stock | M | 4221 | $20.53 | Acquired | 108550 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-24 | Employee stock option (right to buy) | $16.0 | M | 21855 | Disposed | 2023-10-09 | Common Stock (21855.0) | Direct |
| 2021-06-24 | Employee stock option (right to buy) | $20.53 | M | 4221 | Disposed | 2027-02-15 | Common Stock (4221.0) | Direct |
Footnotes
F1: 12.5% of the shares underlying the grant became exercisable on the date reflected and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.
More from MACROGENICS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Regulatory Filings
2026
May 13
Merger & Acquisition
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Board/Management Information
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18